These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8304208)

  • 1. Folate metabolites as modulators of antitumor drug activity.
    Priest DG; Schmitz JC; Bunni MA
    Adv Exp Med Biol; 1993; 338():693-8. PubMed ID: 8304208
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
    Culy CR; Clemett D; Wiseman LR
    Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evidence for a significant role of folylpolyglutamate synthase in combined chemotherapy with oral fluoropyrimidine, UFT or S-1, and leucovorin.
    Tsukioka S; Sakamoto E; Tsujimoto H; Nakagawa F; Saito H; Uchida J; Kiniwa M; Fukushima M
    Oncol Rep; 2011 May; 25(5):1407-12. PubMed ID: 21380490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.
    Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G
    Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical modulation of fluorouracil with leucovorin and interferon: preclinical and clinical investigations.
    Grem JL; Chu E; Boarman D; Balis FM; Murphy RF; McAtee N; Allegra CJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):36-44. PubMed ID: 1557656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid handling by the human gut: implications for food fortification and supplementation.
    Patanwala I; King MJ; Barrett DA; Rose J; Jackson R; Hudson M; Philo M; Dainty JR; Wright AJ; Finglas PM; Jones DE
    Am J Clin Nutr; 2014 Aug; 100(2):593-9. PubMed ID: 24944062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
    Bjelogrlić SK; Srdić T; Radulović S
    J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin in untreated advanced colorectal cancer patients.
    Nobile MT; Canobbio L; Sobrero A; Galligioni E; Vidili MG; Fassio T; Lo Re G; Rubagotti A; Sertoli MR; Rosso R
    Adv Exp Med Biol; 1988; 244():213-8. PubMed ID: 3073656
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in the treatment of advanced colorectal cancer].
    Díaz-Rubio E
    Rev Clin Esp; 1990 Apr; 186(6):292-300. PubMed ID: 1697421
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Fluorouracil and folinic acid: summary of clinical experience.
    Creaven PJ
    Adv Exp Med Biol; 1988; 244():303-11. PubMed ID: 3073664
    [No Abstract]   [Full Text] [Related]  

  • 11. Folate and chemoprevention of colorectal cancer: Is 5-methyl-tetrahydrofolate an active antiproliferative agent in folate-treated colon-cancer cells?
    Akoglu B; Faust D; Milovic V; Stein J
    Nutrition; 2001; 17(7-8):652-3. PubMed ID: 11448589
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of Folate Pathway Genes in Stage III Colorectal Cancer Correlates with Recurrence Status Following Adjuvant Bolus 5-FU-Based Chemotherapy.
    Odin E; Sondén A; Gustavsson B; Carlsson G; Wettergren Y
    Mol Med; 2015 Jul; 21(1):597-604. PubMed ID: 26193446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Enigma of fluorouracil and levamisole.
    Healy JB
    J Natl Cancer Inst; 1995 Oct; 87(19):1486. PubMed ID: 7674336
    [No Abstract]   [Full Text] [Related]  

  • 14. On 5-fluorouracil therapy of colorectal cancer.
    Jensen SA
    Dan Med J; 2013 Jul; 60(7):B4603. PubMed ID: 23809976
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of dose, schedule and route of administration of 5-formyltetra-hydrofolate: preclinical and clinical investigations.
    Rustum YM; Liu L; Zhang Z
    Adv Exp Med Biol; 1988; 244():39-52. PubMed ID: 3266828
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of 5-fluorouracil efficacy.
    Herrmann R
    Cancer Treat Rev; 1990 Sep; 17(2-3):209-12. PubMed ID: 2272035
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction in γ-glutamyl hydrolase expression is associated with response to uracil and tegafur/leucovorin chemotherapy in patients with colorectal cancer.
    Sadahiro S; Suzuki T; Tanaka A; Okada K; Kamijo A; Nagase H; Uchida J
    Anticancer Res; 2013 Aug; 33(8):3431-8. PubMed ID: 23898115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil combined with the pure [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study of two consecutive regimens.
    Machover D; Grison X; Goldschmidt E; Zittoun J; Lotz JP; Metzger G; Richaud J; Hannoun L; Marquet J; Guillot T
    Adv Exp Med Biol; 1993; 339():81-95; discussion 97-8. PubMed ID: 8178732
    [No Abstract]   [Full Text] [Related]  

  • 19. Pretreatment Serum Folate Levels and Toxicity/Efficacy in Colorectal Cancer Patients Treated With 5-Fluorouracil and Folinic Acid.
    Yan M; Ho C; Winquist E; Jonker D; Rayson D; Stitt L; Tokmakejian S; Tomiak A; Vincent MD
    Clin Colorectal Cancer; 2016 Dec; 15(4):369-376.e3. PubMed ID: 27474080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients.
    Geisler J; Geisler SB; Lønning PE; Smaaland R; Tveit KM; Refsum H; Ueland PM
    Clin Cancer Res; 1998 Sep; 4(9):2125-8. PubMed ID: 9748129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.